# Y90 Radioembolization Prior to Surgical Resection or Radiofrequency for Hepatocellular Carcinoma in Cirrhotic Liver

> **NCT01686880** · PHASE2 · TERMINATED · sponsor: **Jules Bordet Institute** · enrollment: 10 (actual)

## Conditions studied

- Hepatocellular Carcinoma
- Liver Cirrhosis

## Interventions

- **DEVICE:** Sirsphere trans-arterial radioembolization

## Key facts

- **NCT ID:** NCT01686880
- **Lead sponsor:** Jules Bordet Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-09
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** poor recruitment and an unexpected low treatment rate
- **Last updated:** 2015-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01686880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01686880, "Y90 Radioembolization Prior to Surgical Resection or Radiofrequency for Hepatocellular Carcinoma in Cirrhotic Liver". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01686880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*